CAR-TCR Summit Europe 2018

Start Date : February 20, 2018
End Date : February 22, 2018
Time : 8:00 am to6:00 pm

Phone : +44 (0)20 3141 8700
Email : info@hansonwade.com

Location :
The Tower Hotel, St Katharine's Way, London, E1W 1LD, United Kingdom

Website

Description

CAR-TCR Summit Europe is the leading end-to-end summit focused on delivering safe, effective and commercially successful CAR and TCR cell therapies globally.


 


With the first CAR-T approved and the next poised to receive approval from the FDA and EMA by the end of 2017, CAR-T therapies aren't going anywhere and are set to become mainstream frontline cancer treatments.


 


As we see success, there are still two key areas even for the leaders to address: European regulations and global distribution. Alongside this, addressing the challenges with improving the underwhelming performance of CAR-TCR therapies in solid tumor indications are more important now than ever before. 


 


CAR-TCR Summit Europe brings you access to the leaders in this field and the hub of companies creating novel innovations in Europe. We set the stage for visionary leaders to transform the commercial and clinical delivery of cancer therapeutics.


 


Gain exclusive insight on current clinical programs and case studies on the next wave of CAR-TCR candidates from those pioneering in this field.


 


Focusing on navigating the regulatory minefield and ensuring successful global distribution and delivery of CAR-T and TCR therapies, CAR-TCR Summit Europe is your opportunity to network, interact and learn at the only end-to-end meeting that fosters the transformation of leading science to commercial therapies.


 


URL:


Brochure: https://go.evvnt.com/169511-1


 


Prices: 


Gold: Conference + 2 Workshops: GBP 2497


Silver: Conference + 1 Workshop: GBP 2098


Bronze: Conference Only: GBP 1699


Workshop Only: GBP 499


 


Speakers: Jian Irish, SVP, Supply Chain, Kite Pharma, Lothar Germeroth, SVP, Managing Director, Juno Therapeutics, Isaac  Ciechanover, CEO, Atara Biotherapeutics, Jens Hasskarl, Senior Director, Medical, Clinical Research And Development, Celgene, John Maher, CSO, Leucid Bio, Thierry Wurch, Director. Immuno-Oncology External Research And Innovation, Servier, Helen Tayton-Martin, CBO, Adaptimmune, Representative to be confirmed, Cellectis, Dolores Schendel, CEO, Medigene, Elisa Kieback, CEO, T-Knife, Michael Leek, CEO, TC Biopharm, Oezlem Anak, Senior Global Clinical Programme Head, Cell And Gene Therapies, Novartis, Martina Schussler-Lenz, Chair CAT, EMA, Miltenyi Biotec, ACD.

Registration Info

Register Now

 

Organized by

Organized by LoveEvvnt1

Hanson Wade


Event Categories: Oncology.

Your Review

You must be logged in to post a comment.